Lodoxamide

Synopsis, Chemistry

APIs // Active Pharmaceutical Ingredients

1 NDC API

1 NDC API

List of Suppliers

Full Screen View

Reset Filter

Price Info

CARBOGEN AMCIS AG

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

Switzerland

Virtual Booth

Digital Content

LODOXAMIDE

PDF Supplier PDF

URL Supplier Web Content

Active Ingredient

Lodoxamide

Dosage Form (Strength)

POWDER (1kg/kg)

Marketing Category

BULK INGREDIENT

NDC Package Code

58567-102

Start Marketing Date

2014-06-01

End Marketing Date

2024-12-31

ASK
US

Upload
your Marketing & Sales content

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Looking for 53882-12-5 / Lodoxamide API manufacturers, exporters & distributors?

PharmaCompass offers a list of Lodoxamide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Lodoxamide manufacturer or Lodoxamide supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Lodoxamide manufacturer or Lodoxamide supplier.

PharmaCompass also assists you with knowing the Lodoxamide API Price utilized in the formulation of products. Lodoxamide API Price is not always fixed or binding as the Lodoxamide Price is obtained through a variety of data sources. The Lodoxamide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Lodoxamide

Synonyms

53882-12-5, Lodoxamidum, 2-[2-chloro-5-cyano-3-(oxaloamino)anilino]-2-oxoacetic acid, U-42585e (free acid), Spu695od73, Lodoxamide (inn)

Cas Number

53882-12-5

Unique Ingredient Identifier (UNII)

SPU695OD73

About Lodoxamide

Lodoxamide is a synthetic mast cell stabilizing compound with anti-inflammatory activity. Lodoxamide appears to inhibit the antigen-stimulated calcium transport across the mast cell membrane, thereby inhibiting mast cell degranulation and the release of histamine, leukotrienes, and other substances that cause hypersensitivity reactions. Lodoxamide also inhibits eosinophil chemotaxis. When applied topically to the eye, this drug prevents the symptoms associated with keratitis or conjunctivitis.

Lodoxamide Manufacturers

A Lodoxamide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Lodoxamide, including repackagers and relabelers. The FDA regulates Lodoxamide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Lodoxamide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

Lodoxamide Suppliers

A Lodoxamide supplier is an individual or a company that provides Lodoxamide active pharmaceutical ingredient (API) or Lodoxamide finished formulations upon request. The Lodoxamide suppliers may include Lodoxamide API manufacturers, exporters, distributors and traders.

Lodoxamide NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Lodoxamide as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Lodoxamide API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Lodoxamide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Lodoxamide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Lodoxamide NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Lodoxamide suppliers with NDC on PharmaCompass.

Lodoxamide Manufacturers | Traders | Suppliers

We have 1 companies offering Lodoxamide

Get in contact with the supplier of your choice:

CARBOGEN AMCIS AG

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.